Lower trust in artificial intelligence than physicians coexists with high willingness to engage in artificial intelligence‐assisted prostate cancer management among active surveillance patients
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Objectives This study aimed to examine the sentiment for artificial intelligence (AI) among prostate cancer (PCa) patients on active surveillance (AS) and to evaluate how that sentiment relates to patient willingness to engage with AI. Materials and Methods We conducted a 23‐question online survey (November–December 2025) distributed through an AS platform. Analyses were restricted to 110 respondents with PCa on AS. Outcomes included trust ratings (10‐point Likert scale) for physicians versus AI, responses to hypothetical AI management recommendations and perceived concerns and facilitators of trust. Statistical analyses included the Wilcoxon signed‐rank tests, the McNemar tests and Fisher's exact tests. Results Median trust in urologists (8 [IQR 7–9]) exceeded that for AI (6 [IQR 5–7]), with smaller differences for radiologists and pathologists compared with diagnostic AI (all p ≤ 0.001). Despite lower trust in AI, most respondents anticipated improved PCa outcomes with AI integration. High willingness to consider AI recommendations was also observed. Only 4.6% ( n = 5) of respondents outright rejected AI recommendation for treatment and only 3.7% ( n = 4) rejected AI recommendation for AS, with all others willing to consider AI recommendations. No respondents fully accepted AI recommendation for treatment without additional verification, whereas 2.8% ( n = 3) fully accepted AI recommendations for continued surveillance. Primary concerns included AI errors (57.3%) and lack of human oversight (48.2%). Conclusions Among AS patients, lower trust in AI compared to physicians coexists with a high optimism for AI and willingness to incorporate AI recommendations into decision‐making. This discordance suggests that behavioural adoption of AI‐assisted care may precede full patient confidence.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Lower trust in artificial intelligence than physicians coexists with high willingness to engage in artificial intelligence‐assisted prostate cancer management among active surveillance patients
- Date Crossref
- 01/09/2026
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Miami pays non établi dans la noticeUniversité ou école supérieure
-
Sylvester Comprehensive Cancer Center pays non établi dans la noticeÉtablissement de santé
-
University of Missouri–Kansas City pays non établi dans la noticeUniversité ou école supérieure
-
Nova Southeastern University pays non établi dans la noticeUniversité ou école supérieure
-
Johns Hopkins University pays non établi dans la noticeUniversité ou école supérieure
-
Johns Hopkins Medicine pays non établi dans la noticeÉtablissement de santé
-
Johns Hopkins Hospital pays non établi dans la noticeÉtablissement de santé
-
School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA pays non établi dans la noticeUniversité ou école supérieure
-
Brady Urology Institute Johns Hopkins School of Medicine Baltimore Maryland USA pays non établi dans la noticeUniversité ou école supérieure
-
Freelance Medical Journalist at “The Active Surveillor” USA pays non établi dans la noticeInstitution
University of Miami, Sylvester Comprehensive Cancer Center et University of Missouri–Kansas City, avec 7 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.